Skip to main content
. 2020 Jan 8;9(1):173. doi: 10.3390/jcm9010173

Figure A3.

Figure A3

The use of pulmonary hypertension targeted therapies in registry patients. A total of 26 patients were participants in clinical trials at the time of enrollment, including 4 in randomized double-blind placebo-controlled trials and 23 in open-label extension studies.